Urological Disorders Resource Center
Click on the subcategory below to find drug monographs for that particular area.
Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Patient Information Fact Sheets
Download or print easy-to-read disease leaflets for your patients.
Keryx announced the launch of Auryxia (ferric citrate) tablets to control serum phosphorous levels in patients with chronic kidney disease (CKD) on dialysis.
Psoriasis may be associated with a higher risk of developing chronic kidney disease (CKD) and glomerulonephritis (GN).
The risk of diabetes mellitus is not increased with thiazide diuretic prophylaxis for kidney stones, according to new research.
Cubist announced that the Food and Drug Administration (FDA) has approved Zerbaxa (ceftolozane/tazobactam) Injection for the treatment of adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI) caused by susceptible Gram-negative bacteria.
In-house clinics can be a cost-efficient way to provide high-quality healthcare, without having to make a large investment.
Some researchers are not convinced that high blood levels of omega-3 fatty acids are associated with an increased PCa risk.
Prostate cancer is the most common male-related malignancy in the US, the second most common cause of cancer-related death among men.
Featured courses from mycme
With acute kidney injury often encountered in the outpatient setting, primary-care providers should know the ...
Today many men are seeking information and treatment for hypogonadism, often to address issues of ...
Data suggest that clinicians often fail to communicate adequately with patients to select individualized therapy. ...
- Over 50 FDA-Approved Meds Could Treat Ebola Infection
- Pharmacy Employees Arrested, Charged in Meningitis Outbreak
- How Effective Are Neuraminidase Inhibitors in Containing Flu?
- Ondansetron, Tramadol Drug Interaction Identified
- Pain Management in Patients with IBD: Individualizing Treatment Approaches